Genetic variation in the endocannabinoid system and response to Cognitive Behavior Therapy for child anxiety disorders.
Lester KJ., Coleman JRI., Roberts S., Keers R., Breen G., Bögels S., Creswell C., Hudson JL., McKinnon A., Nauta M., Rapee RM., Schneider S., Silverman WK., Thastum M., Waite P., Wergeland GJH., Eley TC.
Extinction learning is an important mechanism in the successful psychological treatment of anxiety. Individual differences in response and relapse following Cognitive Behavior Therapy may in part be explained by variability in the ease with which fears are extinguished or the vulnerability of these fears to re-emerge. Given the role of the endocannabinoid system in fear extinction, this study investigates whether genetic variation in the endocannabinoid system explains individual differences in response to CBT. Children (N = 1,309) with a primary anxiety disorder diagnosis were recruited. We investigated the relationship between variation in the CNR1, CNR2, and FAAH genes and change in primary anxiety disorder severity between pre- and post-treatment and during the follow-up period in the full sample and a subset with fear-based anxiety disorder diagnoses. Change in symptom severity during active treatment was nominally associated (P